EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRSA infection, re‐infection and clinical outcomes in diabetic foot infections

Mehmet A Suludere iD, Orhan K Öz, Lee C Rogers, Dane K Wukich, Matthew Malone iD, Lawrence A Lavery

Wound Repair and Regeneration · 2024

DOI: 10.1111/wrr.13164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wound Repair and Regeneration, 2024. Verfasst von Mehmet A Suludere und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Diabetic Foot, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cardinal Health, American Diabetes Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim was to investigate methicillin‐resistant Staphylococcus aureus (MRSA) incidence, conversion and outcomes in diabetic foot infections (DFIs). This is a pooled patient‐level analysis of combined data sets from two randomised clinical trials including 219 patients admitted to the hospital with moderate or severe DFIs. Intraoperative bone and tissue cultures identified bacterial pathogens. We identified pathogens at index infections and subsequent re‐infections. We identified MRSA conversion (MSSA to MRSA) in re‐infections. MRSA incidence in index infections was 10.5%, with no difference between soft tissue infections (STIs) and osteomyelitis (OM). MRSA conversion occurred in 7.7% of the re‐infections in patients who initially had MSSA in their cultures. Patients with re‐infection were 2.2 times more likely to have MRSA compared to the first infection (10.5% vs. 25.8%, relative risk [RR] = 2.2, p = 0.001). Patients with MRSA had longer antibiotic treatment during the 1‐year follow‐up, compared to other pathogens (other 49.8 ± 34.7 days, MRSA 65.3 ± 41.5 days, p = 0.04). Furthermore, there were no differences in healing, time to heal, length of stay, re‐infection, amputation, re‐ulceration, re‐admission, surgery after discharge and amputation after discharge compared to other pathogens. The incidence of MRSA at the index was 10.5% with no difference in STI and OM. MRSA incidence was 25.8% in re‐infections. The RR of having MRSA was 2.2 times higher in re‐infections. Patients with MRSA used more antibiotics during the 1‐year follow‐up. Furthermore, there were no differences in clinical outcomes compared to other bacterial pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedAgedReinfectionIncidenceOsteomyelitisAmputation, SurgicalSoft Tissue InfectionsWound HealingTreatment Outcome

Stichwörter der Autor:innen

MRSAamputationdiabetesfootinfectionosteomyelitisulcer

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Orthopedic Surgery, University of Texas Health Science Center, San Antonio, Texas, USA.
  • Department of Orthopedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Infectious Diseases and Microbiology, School of Medicine, Western Sydney University, Liverpool, New South Wales, Australia.

ORCID-Profile: Mehmet A Suludere, Matthew Malone

Förderung

  • Cardinal Health
  • American Diabetes Association

Zitieren

APA

Suludere, M. A., Öz, O. K., Rogers, L. C., Wukich, D. K., Malone, M., & Lavery, L. A. (2024). MRSA infection, re‐infection and clinical outcomes in diabetic foot infections. Wound Repair and Regeneration. https://doi.org/10.1111/wrr.13164

Vancouver

Suludere MA, Öz OK, Rogers LC, Wukich DK, Malone M, Lavery LA. MRSA infection, re‐infection and clinical outcomes in diabetic foot infections. Wound Repair and Regeneration. 2024. doi:10.1111/wrr.13164

BibTeX
@article{Suludere2024,
  author = {Suludere, Mehmet A and Öz, Orhan K and Rogers, Lee C and Wukich, Dane K and Malone, Matthew and Lavery, Lawrence A},
  title = {MRSA infection, re‐infection and clinical outcomes in diabetic foot infections},
  journal = {Wound Repair and Regeneration},
  year = {2024},
  doi = {10.1111/wrr.13164}
}
Kostenlos starten →